8 results
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
- Management and ... Anatomy Deep ... Superficial #Deep #VTE ... #Anatomy #Anticoagulation ... #Algorithm
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
- Management and ... Anatomy Deep ... Superficial #Deep #VTE ... #Anatomy #Anticoagulation ... #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... randomized controlled trial ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
and Management ... Algorithm #Anticoagulation ... #Breakthrough #Thrombosis ... #Algorithm #Extension ... #VTE #DVT #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... catheter-related thrombosis ... risk of recurrent VTE ... #Anticoagulation ... #Management #Hematology
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Microvascular thrombosis ... Rarely performed Anticoagulation ... pulmonary-artery thrombosis ... and recurrent VTE ... Thromboendarterectomy #diagnosis #management
Endocarditis Summary

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV substance use
• IV catheter
• Recent
Libman Sacks) • Atrial ... • Nonbacterial thrombotic ... • TTE nondiagnostic ... cause + Systemic anticoagulation ... Endocarditis #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Anticoagulation ... • <3mo since VTE ... CARP, DECREASE V trials ... medical and surgical management